NIMVASTID

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, Finland, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug NIMVASTID contains one active pharmaceutical ingredient (API):

1 Rivastigmine UNII PKI06M3IW0 - RIVASTIGMINE

Rivastigmine is an acetyl- and butyrylcholinesterase inhibitor of the carbamate type, thought to facilitate cholinergic neurotransmission by slowing the degradation of acetylcholine released by functionally intact cholinergic neurones. Thus, rivastigmine may have an ameliorative effect on cholinergic-mediated cognitive deficits in dementia associated with Alzheimer’s disease and Parkinson’s disease. Read about Rivastigmine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NIMVASTID Hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06DA03	Rivastigmine	N Nervous system → N06 Psychoanaleptics → N06D Anti-dementia drugs → N06DA Anticholinesterases
Discover more medicines within N06DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 09739669, 09739675, 09739681, 09739698, 09739706, 09739712, 09739729, 09739735
Country: EE	Ravimiamet	Identifier(s): 1420669, 1420670, 1420681, 1420692, 1420704, 1420715, 1420726, 1420737, 1420748, 1420759, 1420760, 1420771, 1420782, 1420793, 1420805, 1420816, 1420827, 1420838, 1420849, 1420850, 1420861, 1420872, 1420883, 1420894, 1420906, 1420917, 1420928, 1420939, 1420940, 1420951, 1420962, 1420973, 1420984, 1420995, 1421008, 1421019, 1421020, 1421031, 1421042, 1421053, 1421064, 1421075, 1421086, 1421097, 1421109, 1470495, 1470507, 1470518, 1470529, 1470675
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 109525004, 109525012, 109525016, 109525018, 109525022, 109525024
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 081681, 139959, 159762, 481345
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 197223, 197231, 197235, 197238
Country: IE	Health Products Regulatory Authority	Identifier(s): 24472, 24473, 24474, 24475
Country: IT	Agenzia del Farmaco	Identifier(s): 041673043, 041673106, 041673169, 041673221
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1037908, 1037909, 1037910, 1037911, 1037912, 1037913, 1037914, 1037915, 1037916, 1037917, 1037918, 1037919, 1037920, 1037921, 1037922, 1037923, 1037924, 1037925, 1037926, 1037928, 1037929, 1037930, 1037931, 1037932, 1037933, 1037934, 1037935, 1037936, 1037937, 1037938, 1037939, 1037940, 1037941, 1037942, 1037943, 1037944, 1037995, 1037996, 1037997, 1037998, 1037999, 1038000, 1038001, 1038002, 1038003, 1038004, 1054660, 1054661, 1054662, 1056546
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100209493, 100209518, 100209530, 100209547, 100210941, 100210958, 100210964, 100210970
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W54535001, W54535002, W54535003, W54535004, W54535005, W54535006, W54536001, W54536002, W54536003, W54536004, W54536005, W54536006, W54536007, W54537001, W54537002, W54537003, W54537004, W54537005, W54537006, W54538001, W54538002, W54538003, W54538004, W54538005, W54538006, W54539001, W54539002, W54539003, W54539004, W54539005, W54540001, W54540002, W54540003, W54540004, W54540005, W54541001, W54541002, W54541003, W54541004, W54541005, W54542001, W54542002, W54542003, W54542004, W54542005